Fundraising FoxBlackstone Life Sciences — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Talaris Therapeuticstalaristx.comApr 2019
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
BiotechLouisville, US
Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)
BoardSandip Agarwala(Director)inMark McDade(Director)in
Co-investorsAisling CapitalKeyhorse CapitalLongitude CapitalQiming Venture Partners USAViking GlobalCitadel+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.